Addenda Capital Inc. reduced its stake in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 9.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,200 shares of the company’s stock after selling 4,279 shares during the period. Addenda Capital Inc.’s holdings in Procter & Gamble were worth $5,618,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Halbert Hargrove Global Advisors LLC bought a new stake in shares of Procter & Gamble during the third quarter valued at approximately $25,000. Saranac Partners Ltd bought a new position in shares of Procter & Gamble during the 3rd quarter valued at $30,000. Corundum Trust Company INC bought a new position in shares of Procter & Gamble during the 3rd quarter valued at $32,000. Caitlin John LLC bought a new position in shares of Procter & Gamble during the 3rd quarter valued at $34,000. Finally, Marquette Asset Management LLC bought a new position in shares of Procter & Gamble during the 3rd quarter valued at $37,000. 65.77% of the stock is owned by institutional investors.
Procter & Gamble Trading Up 2.6%
Shares of Procter & Gamble stock opened at $145.00 on Thursday. The company has a market capitalization of $336.98 billion, a P/E ratio of 21.48, a P/E/G ratio of 5.04 and a beta of 0.41. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72. The company has a fifty day moving average of $153.23 and a 200 day moving average of $149.32. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $171.65.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, February 17th. Shareholders of record on Friday, January 23rd were issued a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend was Friday, January 23rd. Procter & Gamble’s dividend payout ratio is 62.67%.
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, CEO Gary A. Coombe sold 36,093 shares of the stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $162.33, for a total transaction of $5,858,976.69. Following the completion of the transaction, the chief executive officer owned 34,994 shares of the company’s stock, valued at $5,680,576.02. This represents a 50.77% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Balaji Purushothaman sold 12,827 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $160.31, for a total transaction of $2,056,296.37. Following the transaction, the insider directly owned 12,639 shares of the company’s stock, valued at $2,026,158.09. This trade represents a 50.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 348,618 shares of company stock worth $55,462,643. Insiders own 0.20% of the company’s stock.
Procter & Gamble News Roundup
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: P&G announced a multi‑year, multi‑brand partnership as an official partner of the WNBA, which should boost consumer engagement and brand visibility across younger and sports audiences. P&G Enters New Era in Sports as Official Partner of the WNBA
- Positive Sentiment: UBS trimmed its price target to $166 but maintained a “buy” rating, signaling continued analyst conviction in P&G’s long‑term growth despite the lower PT. UBS PT Change
- Positive Sentiment: Wells Fargo cut its PT to $158 but kept an “overweight” rating, which reinforces a favorable view among some institutional analysts and may support buying interest. Wells Fargo Adjusts PT
- Positive Sentiment: Coverage highlighting P&G’s “lifeblood” innovation strategy and how management is leaning into new product/marketing initiatives is helping the turnaround narrative and investor sentiment. Jim Cramer on P&G Innovation Strategy
- Neutral Sentiment: Market commentary explaining why P&G outpaced the market today provides context for the move but is descriptive rather than new fundamental information. Why P&G Outpaced the Market
- Neutral Sentiment: Goldman Sachs trimmed its PT to $155 and kept a “neutral” rating — a mixed signal that lowers upside expectations but stops short of turning bearish. Goldman Sachs Adjusts PT
- Negative Sentiment: Piper Sandler cut its PT to $142 and maintained a “neutral” rating; the new PT sits below the current price, implying downside from today’s levels and adding short‑term pressure. Piper Sandler Adjusts PT
- Negative Sentiment: Recent coverage noting a day when PG shares declined reflects ongoing volatility and reminds investors that near‑term sentiment can swing on news/analyst moves. P&G Stock Sinks Coverage
Analysts Set New Price Targets
Several research firms have recently weighed in on PG. Piper Sandler lowered their price target on Procter & Gamble from $150.00 to $142.00 and set a “neutral” rating on the stock in a report on Wednesday. Dbs Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating in a research report on Friday, January 23rd. JPMorgan Chase & Co. raised shares of Procter & Gamble from a “neutral” rating to an “overweight” rating and boosted their price objective for the company from $157.00 to $165.00 in a research report on Friday, January 23rd. Jefferies Financial Group raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and boosted their price objective for the company from $156.00 to $179.00 in a research report on Tuesday, December 16th. Finally, Rothschild & Co Redburn boosted their price objective on shares of Procter & Gamble from $155.00 to $157.00 and gave the company a “neutral” rating in a research report on Friday, January 23rd. Twelve research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $164.79.
Get Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
